Source: Υπουργείο Υγείας (CY) Revision Year: 2017 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medovent 30 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Tablets are white, flat, round, scored with 8 mm diameter. The score line is not intended for breaking the tablet. |
Each tablet contains 30mg ambroxol hydrochloride.
Excipient with known effect: lactose. Each Medovent 30 mg tablet contains 134 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ambroxol |
Ambroxol induces activation of the surfactant system by acting directly on the type II pneumocytes of the alveoles and the Clara cells in the region of the small airways. It promotes the formation and outward transfer of surface-active material in the alveolar and bronchial region of the foetal and adult lungs. |
| List of Excipients |
|---|
|
Lactose |
Polyvinylchloride film-aluminium foil blisters, with a patient information leaflet in a card carton. Packs containing 20, 30, 50 and 60 tablets are available.
Polyvinylchloride securitainers with a tamper evident closure containing 250, 500, or 1000 tablets are also available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
11437
First authorization: 23/10/1987
Renewal authorization: 07/04/2010
| Drug | Countries | |
|---|---|---|
| MEDOVENT | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
